AI assistant
Sending…
DAVITA INC. — Director's Dealing 2012
Nov 16, 2012
30643_dirs_2012-11-16_ae5b80cf-c841-4aef-9596-0fb44978df35.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2012-11-15
Reporting Person: Nissenson Allen (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-11-15 | Common Stock | M | 7000 | $46.26 | Acquired | 7925 | Direct |
| 2012-11-15 | Common Stock | F | 2890 | $112.05 | Disposed | 5035 | Direct |
| 2012-11-15 | Common Stock | S | 4110 | $112.50 | Disposed | 925 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-11-15 | Stock Appreication Right | $46.26 | M | 7000 | Disposed | 2014-03-02 | Common Stock (7000) | Direct |
Footnotes
F1: Stock Appreciation Right, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 25% on the first anniversary of the grant date, 8.33% on the 20th month following the grant date, and 8.33% every four months thereafter.
More from DAVITA INC.
Interim / Quarterly Report
2026
May 5
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Annual Report
2026
Feb 11
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Earnings Release
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2025
Dec 5
Capital/Financing Update
2025
Nov 25